“Some pharmaceutical companies shut down Facebook pages, while others monitored and deleted visitor comments, after the social media site on Aug. 15 stopped giving drug companies the option of preventing public comments on their pages.
Facebook had allowed pharmaceutical companies to request that their commenting features be turned off, which many took advantage of because of confusion about whether the Food and Drug Administration would require companies to report adverse drug events disclosed on social media. Physician and hospital Facebook pages have not been allowed to disable comments.”
Article
Pamela Lewis Dolan, amednews, 29 August 2011
